Department of Chemistry, Alfaisal University, Al Zahrawi Street, Al Maather, Al Takhassusi Road, Riyadh, 11533, Saudi Arabia.
Faculty of Applied Medical Sciences, King Abdulaziz University, P. O. Box 80402, Jeddah, 21589, Kingdom of Saudi Arabia.
Mikrochim Acta. 2021 May 26;188(6):199. doi: 10.1007/s00604-021-04867-1.
Since the COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) was declared a pandemic, it has spread rapidly, causing one of the most serious outbreaks in the last century. Reliable and rapid diagnostic tests for COVID-19 are crucial to control and manage the outbreak. Here, a label-free square wave voltammetry-based biosensing platform for the detection of SARS-CoV-2 in nasopharyngeal samples is reported. The sensor was constructed on screen-printed carbon electrodes coated with gold nanoparticles. The electrodes were functionalized using 11-mercaptoundecanoic acid (MUA) which was used for the immobilization of an antibody against SARS-CoV-2 nucleocapsid protein (N protein). The binding of the immunosensor with the N protein caused a change in the electrochemical signal. The detection was realised by measuring the change in reduction peak current of a redox couple using square wave voltammetry at 0.04 V versus Ag ref. electrode on the immunosensor upon binding with the N protein. The electrochemical immunosensor showed high sensitivity with a linear range from 1.0 pg.mL to 100 ng.mL and a limit of detection of 0.4 pg.mL for the N protein in PBS buffer pH 7.4. Moreover, the immunosensor did not exhibit significant response with other viruses such as HCoV, MERS-CoV, Flu A and Flu B, indicating the high selectivity of the sensor for SARS-CoV-2. However, cross reactivity of the biosensor with SARS-CoV is indicated, which gives ability of the sensor to detect both SARS-CoV and SARS-CoV-2. The biosensor was successfully applied to detect the SARS-CoV-2 virus in clinical samples showing good correlation between the biosensor response and the RT-PCR cycle threshold values. We believe that the capability of miniaturization, low-cost and fast response of the proposed label-free electrochemical immunosensor will facilitate the point-of-care diagnosis of COVID 19 and help prevent further spread of infection.
自新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)引起的 COVID-19 疾病被宣布为大流行以来,它迅速传播,造成了上个世纪最严重的疫情之一。可靠和快速的 COVID-19 诊断测试对于控制和管理疫情至关重要。在这里,报道了一种用于检测鼻咽样本中 SARS-CoV-2 的无标记方波伏安生物传感平台。该传感器构建在涂有金纳米粒子的丝网印刷碳电极上。电极通过 11-巯基十一酸(MUA)功能化,用于固定针对 SARS-CoV-2 核衣壳蛋白(N 蛋白)的抗体。免疫传感器与 N 蛋白的结合引起电化学信号的变化。通过在与 N 蛋白结合时使用方波伏安法在 0.04 V 相对于 Ag 参比电极测量电化学免疫传感器上氧化还原对的还原峰电流变化来实现检测。电化学免疫传感器在 PBS 缓冲液 pH 7.4 中对 N 蛋白的线性范围为 1.0 pg.mL 至 100 ng.mL,检测限为 0.4 pg.mL,具有很高的灵敏度。此外,免疫传感器与其他病毒如 HCoV、MERS-CoV、Flu A 和 Flu B 没有明显的反应,表明传感器对 SARS-CoV-2 具有很高的选择性。然而,生物传感器与 SARS-CoV 的交叉反应表明,传感器能够同时检测 SARS-CoV 和 SARS-CoV-2。该生物传感器成功地应用于临床样本中 SARS-CoV-2 病毒的检测,生物传感器的响应与 RT-PCR 循环阈值之间具有良好的相关性。我们相信,所提出的无标记电化学免疫传感器的小型化、低成本和快速响应能力将有助于 COVID-19 的即时诊断,并有助于防止感染的进一步传播。